---
schema_version: "secwatch.filing_event.v1"
accession: "0001641172-25-008841"
form_type: "8-K"
ticker: "LFMD"
cik: "0000948320"
company_name: "LifeMD, Inc."
filed_at: "2025-05-06T23:59:59+00:00"
generated_at: "2026-05-22T16:00:39.427860+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# LifeMD Q1 revenue up 49% to $65.7M; first GAAP profit; raises FY 2025 guidance

## Summary
- Total revenue $65.7M (+49% YoY); telehealth revenue up 70% to $55.8M.
- GAAP net income $0.6M ($0.01 diluted EPS), first-ever positive GAAP EPS.
- Adj. EBITDA $8.7M (vs. $0.1M); telehealth adj. EBITDA $5.3M (vs. -$1.3M).
- FY 2025 guidance raised: revenue $268-275M, adj. EBITDA $31-33M.
- Partnered with LillyDirect/NovoCare for branded GLP-1 access (Zepbound, Wegovy).

## SEC filing metadata
- accession: 0001641172-25-008841
- form_type: 8-K
- ticker: LFMD
- cik: 0000948320
- company_name: LifeMD, Inc.
- filed_at: 2025-05-06T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/948320/000164117225008841/0001641172-25-008841-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/948320/000164117225008841/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001641172-25-008841
- JSON: https://secwatch.observer/filing/0001641172-25-008841.json
- Plain text: https://secwatch.observer/filing/0001641172-25-008841.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.